Mesirow-Financial-Investment-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-08
Total Holdings
593
Total Value
5160168880
Accession Number
0001085146-25-002744
Form Type
13F-HR
Manager Name
Mesirow-Financial-Investment-Management
Data Enrichment
84% identified
496 identified97 unidentified

Holdings

593 positions • $5.2B total value
Manager:
Search and click to pin securities to the top
Page 30 of 30
Douglas Elliman Inc.
Shares:18.5K
Value:$31.8K
% of Portfolio:0.0% ($31.8K/$5.2B)
Esperion Therapeutics, Inc.
Shares:20.0K
Value:$28.8K
% of Portfolio:0.0% ($28.8K/$5.2B)
KORU Medical Systems, Inc.
Shares:11.0K
Value:$27.8K
% of Portfolio:0.0% ($27.8K/$5.2B)
ThredUp Inc.
Shares:10.7K
Value:$25.8K
% of Portfolio:0.0% ($25.8K/$5.2B)
NEPHROS INC
Shares:13.8K
Value:$23.7K
% of Portfolio:0.0% ($23.7K/$5.2B)
NEW PACIFIC METALS CORP
Shares:20.0K
Value:$22.1K
% of Portfolio:0.0% ($22.1K/$5.2B)
LIQTECH INTERNATIONAL INC
Shares:13.8K
Value:$20.5K
% of Portfolio:0.0% ($20.5K/$5.2B)
Lineage Cell Therapeutics, Inc.
Shares:20.0K
Value:$9.0K
% of Portfolio:0.0% ($9.0K/$5.2B)
Vaxart, Inc.
Shares:20.0K
Value:$8.1K
% of Portfolio:0.0% ($8.1K/$5.2B)
SANGAMO THERAPEUTICS, INC
Shares:11.8K
Value:$7.7K
% of Portfolio:0.0% ($7.7K/$5.2B)
N94209108
Shares:10.0K
Value:$3.3K
% of Portfolio:0.0% ($3.3K/$5.2B)
P3 Health Partners Inc.
Shares:15.0K
Value:$2.5K
% of Portfolio:0.0% ($2.5K/$5.2B)
N94209116
Shares:15.0K
Value:$332
% of Portfolio:0.0% ($332/$5.2B)